SCHEMBL8499693

SCHEMBL8499693

O=C(O)c1ccc2ncc(-c3cccc(F)c3)cc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 2/20 0.52
PDGFRA P16234 2/20 0.52
CSNK2A2 P19784 1/20 0.51
CSNK2B P67870 1/20 0.51
MAP4K4 O95819 1/20 0.49
CSNK1G2 P78368 1/20 0.49
CLK4 Q9HAZ1 1/20 0.49
MKNK2 Q9HBH9 1/20 0.49
MAP4K5 Q9Y4K4 1/20 0.49
CHEK2 O96017 1/20 0.48
MGAM O43451 1/20 0.48
KMO O15229 2/20 0.47
HPGDS O60760 1/20 0.47
KDM4C Q9H3R0 2/20 0.46
KDM5A P29375 1/20 0.46
KDM5B Q9UGL1 1/20 0.46
KDM4E B2RXH2 1/20 0.46
NPC1 O15118 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8889438 0.93 PDGFRB (0.55) PDGFRBPDGFRACSNK2A2CSNK2BMAP4K4
SCHEMBL8502256 0.89 CSNK2A2 (0.54) PDGFRBPDGFRACSNK2A2CSNK2BMAP4K4
SCHEMBL4123055 0.87 MGAM (0.58) PDGFRBPDGFRAMAP4K4CSNK1G2CLK4
SCHEMBL8503378 0.84 PDGFRB (0.57) PDGFRBPDGFRAMAP4K4CSNK1G2CLK4
Hydrochloric Acid SCHEMBL8891443 0.83 PDGFRB (0.53) PDGFRBPDGFRACSNK2A2CSNK2BMAP4K4
SCHEMBL8502612 0.81 CDK8 (0.58) PDGFRBPDGFRAMAP4K4CSNK1G2CLK4
SCHEMBL8887303 0.81 DCLRE1B (0.58) PDGFRBPDGFRAMAP4K4CSNK1G2CLK4
SCHEMBL8503239 0.81 DHODH (0.49) PDGFRBPDGFRAMAP4K4CSNK1G2CLK4
SCHEMBL8503241 0.79 KMT2A (0.50) PDGFRBPDGFRAMAP4K4CSNK1G2CLK4
SCHEMBL8499648 0.79 PDE3B (0.55) PDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US claimed
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 US disclosed
US-5795889-A INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-08-18 US disclosed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 US disclosed